In TRIUMPH-1 and TRANSCEND-T2D-1, treatment with retatrutide resulted in substantial weight reduction together with clinically meaningful improvements in glycemia, knee osteoarthritis pain, and obstructive sleep apnea, with many individuals reaching what are classified as healthy-range weight and normal blood sugar levels. Retatrutide is an investigational once-weekly single molecule that activates the bodys receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
The peptides impact on gene expression, particularly in the hippocampus, further underscores its potential in brain health
Subchronic oral toxicity of di-n-octyl phthalate and di (2-ethylhexyl) phthalate in the rat
Depression is not a common side effect of Ozempic, but some people have reported mood changes while using it
To make it work, they had to use specialized coatings, absorption enhancers, and strict dosing instructions